comunicacio

Science and the street meet in Sinergia, the IDIBELL open day

This past Saturday, June 14, science coloured the Bellvitge neighbourhood thanks to Sinergia, the open doors of IDIBELL and the Bellvitge health campus with the support of the City Council of L’Hospitalet del Llobregat. It did so with workshops, organised activities, games, and music to get closer to the residents of the city, inviting them […]

Science and the street meet in Sinergia, the IDIBELL open day Read More »

The VINCat Programme, a European benchmark in the fight against hospital infections and antibiotic resistance

During the 20 years of the VINCat Programme, promoted by the Catalan Health Service, measures for the prevention and control of hospital infections have been implemented in almost 200 health centres in the country…

The VINCat Programme, a European benchmark in the fight against hospital infections and antibiotic resistance Read More »

New non-coding genes that cause childhood neurodevelopmental disorders have been identified

An international consortium of scientists, with the participation of Spanish centres such as IDIBELL, CIBERER and the Germans Trias i Pujol University Hospital, has identified genetic variants in essential non-coding genes that cause previously undiagnosed neurodevelopmental disorders (NDDs) in patient cohorts. The findings have been published in the high-impact scientific journal Nature Genetics.   Beyond

New non-coding genes that cause childhood neurodevelopmental disorders have been identified Read More »

“Active recipes” to prevent chronic diseases: the proposal of the +ACTIU project

In Catalonia we spend about 5 and a half hours a day in sedentary behaviour, without moving, which represents a clear risk factor for the development of chronic diseases. The numbers confirm this, given that 2 out of 5 adults have this type of disease. This situation is aggravated by the lack of available outdoor

“Active recipes” to prevent chronic diseases: the proposal of the +ACTIU project Read More »

Telemedicine reduces cardiovascular mortality in chronic heart failure by up to 54%

The combination of telemonitoring and teleintervention reduces episodes of decompensation by 70% and cardiovascular mortality by 54% in people with chronic heart failure.

Telemedicine reduces cardiovascular mortality in chronic heart failure by up to 54% Read More »

Rediscovering denosumab: from osteoporosis treatment to a possible role against breast cancer

The first results of a clinical trial have emerged that reveal the potential for denosumab, an osteoporosis drug, to be used in breast cancer.

Rediscovering denosumab: from osteoporosis treatment to a possible role against breast cancer Read More »

Scroll to Top